Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
暂无分享,去创建一个
S. Ergün | E. Henke | S. Kuerten | M. Schroeter | Nicole Wagner | Nicolai B Grether | M. S. Recks | Alla Ganscher | Franziska van der Broeck
[1] M. Sospedra,et al. Immunology of Multiple Sclerosis , 2016, Seminars in Neurology.
[2] P. Lehmann,et al. The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response. , 2013, Clinical immunology.
[3] M. Levin,et al. Antibodies to an Intracellular Antigen Penetrate Neuronal Cells and Cause Deleterious Effects , 2013 .
[4] P. Lehmann,et al. Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response , 2012, Acta Neuropathologica.
[5] I. Cohen,et al. Antigen microarrays identify CNS-produced autoantibodies in RRMS , 2012, Neurology.
[6] R. Reynolds,et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. , 2011, Brain : a journal of neurology.
[7] P. Lehmann,et al. Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE. , 2011, Clinical immunology.
[8] M. Dalakas,et al. Fine specificity of antibodies against AQP4: epitope mapping reveals intracellular epitopes. , 2011, Journal of autoimmunity.
[9] K. Addicks,et al. Corrigendum to “Emerging concepts in autoimmune encephalomyelitis beyond the CD4/TH1 paradigm” [Ann. Anat. 192 (4) (2010) 179–193] , 2011 .
[10] S. Cepok,et al. The role of antibodies in multiple sclerosis. , 2011, Biochimica et biophysica acta.
[11] D. Cornblath,et al. Evidence-based guideline update: Plasmapheresis in neurologic disorders , 2011, Neurology.
[12] T. Chomiak,et al. What Is the Optimal Value of the g-Ratio for Myelinated Fibers in the Rat CNS? A Theoretical Approach , 2009, PloS one.
[13] K. Berer,et al. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells , 2009, The Journal of experimental medicine.
[14] J. Rosenbluth,et al. Spinal cord dysmyelination caused by an antiproteolipid protein IgM antibody: Implications for the mechanism of central nervous system myelin formation , 2009, Journal of neuroscience research.
[15] P. Lehmann,et al. Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis. , 2008, Clinical immunology.
[16] D. Arnold,et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. , 2008, The New England journal of medicine.
[17] R. Soleti,et al. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[18] Hans Lassmann,et al. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.
[19] P. Lehmann,et al. MBP-PLP fusion protein-induced EAE in C57BL/6 mice , 2006, Journal of Neuroimmunology.
[20] Lawrence Steinman,et al. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis , 2006, Annals of neurology.
[21] S. Miller,et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis , 2005, Nature Medicine.
[22] D. Alarcón-Segovia,et al. Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications. , 2003, Current pharmaceutical design.
[23] Lawrence Steinman,et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis , 2003, Nature Biotechnology.
[24] N. Ruddle,et al. Rat and Human Myelin Oligodendrocyte Glycoproteins Induce Experimental Autoimmune Encephalomyelitis by Different Mechanisms in C57BL/6 Mice1 , 2003, Journal of Immunology.
[25] B. Trapp,et al. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease , 2003, Journal of the Neurological Sciences.
[26] Michael J. Ramsbottom,et al. Critical role of antigen‐specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein , 2002, European journal of immunology.
[27] S. Hauser,et al. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[28] S. Miller,et al. De Novo Central Nervous System Processing of Myelin Antigen Is Required for the Initiation of Experimental Autoimmune Encephalomyelitis1 , 2002, The Journal of Immunology.
[29] R. Maxwell,et al. Marmoset Fine B Cell and T Cell Epitope Specificities Mapped onto a Homology Model of the Extracellular Domain of Human Myelin Oligodendrocyte Glycoprotein , 2002, Neurobiology of Disease.
[30] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[31] I. Sanz,et al. In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies. , 2000, International immunology.
[32] R. Hohlfeld,et al. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. , 1999, Brain : a journal of neurology.
[33] A. Cross,et al. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide , 1999, European journal of immunology.
[34] A. Steck,et al. Anti‐MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening , 1999, Muscle & nerve.
[35] V. Tuohy,et al. Spontaneous Regression of Primary Autoreactivity during Chronic Progression of Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis , 1999, The Journal of experimental medicine.
[36] P. Dalbon,et al. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes , 1998, Journal of Neuroimmunology.
[37] L. Matis,et al. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. , 1998, Journal of immunology.
[38] R. Tafi,et al. Identification of peptides binding to IgG in the CSF of Multiple Sclerosis patients , 1998, Multiple sclerosis.
[39] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[40] H. Hartung,et al. Isolation and characterization of an oligodendrocyte precursor–derived B‐cell epitope in multiple sclerosis , 1998, Annals of neurology.
[41] H. Lassmann,et al. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[42] D. Colman,et al. Conservation of Topology, But Not Conformation, of the Proteolipid Proteins of the Myelin Sheath , 1997, The Journal of Neuroscience.
[43] L. Matis,et al. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. , 1996, The Journal of clinical investigation.
[44] C. Richter-Landsberg,et al. OLN‐93: A new permanent oligodendroglia cell line derived from primary rat brain glial cultures , 1996, Journal of neuroscience research.
[45] D. Alarcón-Segovia,et al. The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage. , 1996, Journal of autoimmunity.
[46] M. Pákáski,et al. Identification and characterization of a B‐cell determinant within the amphipathic domain (residues 178–238) of the myelin proteolipid protein , 1996, Journal of neuroscience research.
[47] D. Isenberg,et al. Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. , 1995, Kidney international.
[48] F. Lieberman,et al. Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity , 1994, Journal of Neuroimmunology.
[49] E. Sercarz,et al. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen , 1992, Nature.
[50] G. M. Hope,et al. Maintenance of myelinated fibre g ratio in acute experimental allergic encephalomyelitis. , 1991, Brain : a journal of neurology.
[51] M. K. Richards,et al. The immune response to myelin proteolipid protein in the Lewis rat: identification of the immunodominant B cell epitope , 1990, Journal of Neuroimmunology.
[52] P. Ho,et al. Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitis. , 2012, Current trends in immunology.
[53] R. Reynolds,et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. , 2007, Brain : a journal of neurology.